Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05779319
Other study ID # KUK-Opthalmology-013
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date September 30, 2025

Study information

Verified date October 2023
Source Johannes Kepler University of Linz
Contact Nino Hirnschall, MD
Phone +435768083
Email nino.hirnschall@kepleruniklinikum.at
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main purpose of the study is to develop an AI approach to improve intraocular lens power calculations.


Description:

Cataract surgery is one of the most commonly performed surgeries worldwide and has a high postoperative patient satisfaction rate. Despite significant improvement in measurement methods and artificial lens power calculation formulas, miscalculations and subsequently refractive error still occur after cataract surgery. Most current artificial lens calculation methods use regression formulas. The concept of artificial intelligence (AI) has only recently found use and only in a rudimentary way. Examples include the Hill-RBF calculator and the Ladas superformula, but at least the "superformula" does not use a true AI approach and the results are no better than those obtained with conventional methods. The main purpose of the study is to develop an AI approach to improve intraocular lens power calculations. The data will be used for the following analysis: - To compare the new AI method with conventional and modern formula (main question) - To compare the refractive error for different eye lengths - To use a ray tracing method to quantify sources of error in patients with a refractive surprise of at least 1.0 diopter - To evaluate a novel concept of outlier testing using a modified nonparametric Walsh test This study will be multi-center and partially prospective. Data from 1000 patients who have already had cataract surgery will be analyzed. All patients will be invited for a visit to the recruitment clinic and the measurements will be performed.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date September 30, 2025
Est. primary completion date July 30, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years to 110 Years
Eligibility Inclusion Criteria: - Pseudophakic (at least one eye): cataract surgery between 4 weeks and 24 months prior to recruitment - If both eyes would be suitable for the study only the right eye will be included, if only one eye is suitable for the study, this eye will be included - Pre-operative swept-source OCT biometry available (no ultrasound measurement for axial eye length) - Uncomplicated cataract surgery - Age 21 years and older Exclusion Criteria: - Multifocal IOLs - Combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery) - Best corrected distance visual acuity below 0.5 Snellen - In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
non contact measurement with the IOL Master 700
postoerpative we will perform non contact measurement with the IOL Master 700

Locations

Country Name City State
Austria Kepler University Klinik Departement of Opthalmology Linz Upperaustria

Sponsors (4)

Lead Sponsor Collaborator
Johannes Kepler University of Linz Landesklinikum Sankt Polten, Medical University of Graz, Mein Hanusch-Krankenhaus

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary a new artificial intelligence based approach for intraocular lens power calculation Developing an artificial intelligence algorithm to predict post-operative refraction 2 years
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A